Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma
Public ClinicalTrials.gov record NCT00323570. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Double-blind, Parallel Group, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Activated Recombinant Factor VII (rFVIIa/NovoSeven®/ NiaStase®) in the Treatment of Refractory Bleeding in Severely Injured Trauma Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in the United States of America (USA). The purpose of this study is to evaluate the treatment of Recombinant Faction VIIa in Patients with Severe Bleeding Due to Trauma Please note that this trial and trial F7TRAUMA-1711 (NCT00184548) have been merged.
Study identification
- NCT ID
- NCT00323570
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2006 (Type not available)
- Primary completion
- Jun 2007 (Actual)
- Completion
- Jun 2007 (Actual)
- Last update posted
- Jun 27, 2012
2006 – 2007
United States locations
- U.S. sites
- 42
- U.S. states
- 26
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Clinical Trial Call Center | Phoenix | Arizona | 85008 | — |
| Novo Nordisk Clinical Trial Call Center | Los Angeles | California | 90033 | — |
| Novo Nordisk Clinical Trial Call Center | Sacramento | California | 95817 | — |
| Novo Nordisk Clinical Trial Call Center | Colorado Springs | Colorado | 80909 | — |
| Novo Nordisk Clinical Trial Call Center | Washington D.C. | District of Columbia | 20010-2975 | — |
| Novo Nordisk Clinical Trial Call Center | Gainesville | Florida | 32610 | — |
| Novo Nordisk Clinical Trial Call Center | Jacksonville | Florida | 32209 | — |
| Novo Nordisk Clinical Trial Call Center | Miami | Florida | 33136 | — |
| Novo Nordisk Clinical Trial Call Center | Chicago | Illinois | 60612 | — |
| Novo Nordisk Clinical Trial Call Center | Maywood | Illinois | 60153 | — |
| Novo Nordisk Clinical Trial Call Center | Indianapolis | Indiana | 46202 | — |
| Novo Nordisk Clinical Trial Call Center | Louisville | Kentucky | 40202 | — |
| Novo Nordisk Clinical Trial Call Center | Portland | Maine | 04102 | — |
| Novo Nordisk Clinical Trial Call Center | Baltimore | Maryland | 21201 | — |
| Novo Nordisk Clinical Trial Call Center | Boston | Massachusetts | 02118 | — |
| Novo Nordisk Clinical Trial Call Center | Detroit | Michigan | 48201 | — |
| Novo Nordisk Clinical Trial Call Center | Springfield | Missouri | 65804 | — |
| Novo Nordisk Clinical Trial Call Center | St Louis | Missouri | 63110-0250 | — |
| Novo Nordisk Clinical Trial Call Center | Las Vegas | Nevada | 89102 | — |
| Novo Nordisk Clinical Trial Call Center | Camden | New Jersey | 08103 | — |
| Novo Nordisk Clinical Trial Call Center | Brooklyn | New York | 11203 | — |
| Novo Nordisk Clinical Trial Call Center | The Bronx | New York | 10461 | — |
| Novo Nordisk Clinical Trial Call Center | Greenville | North Carolina | 27835-6028 | — |
| Novo Nordisk Clinical Trial Call Center | Winston-Salem | North Carolina | 27157 | — |
| Novo Nordisk Clinical Trial Call Center | Akron | Ohio | 44304 | — |
| Novo Nordisk Clinical Trial Call Center | Cleveland | Ohio | 44109 | — |
| Novo Nordisk Clinical Trial Call Center | Columbus | Ohio | 43214 | — |
| Novo Nordisk Clinical Trial Call Center | Oklahoma City | Oklahoma | 73104 | — |
| Novo Nordisk Clinical Trial Call Center | Portland | Oregon | 97239-3098 | — |
| Novo Nordisk Clinical Trial Call Center | Allentown | Pennsylvania | 18103 | — |
| Novo Nordisk Clinical Trial Call Center | Philadelphia | Pennsylvania | 19102 | — |
| Novo Nordisk Clinical Trial Call Center | Philadelphia | Pennsylvania | 19104 | — |
| Novo Nordisk Clinical Trial Call Center | Philadelphia | Pennsylvania | 19140-5189 | — |
| Novo Nordisk Clinical Trial Call Center | Pittsburgh | Pennsylvania | 15213-2582 | — |
| Novo Nordisk Clinical Trial Call Center | Providence | Rhode Island | 02903 | — |
| Novo Nordisk Clinical Trial Call Center | Memphis | Tennessee | 38163 | — |
| Novo Nordisk Clinical Trial Call Center | Nashville | Tennessee | 37212 | — |
| Novo Nordisk Clinical Trial Call Center | Fort Sam Houston | Texas | 78234-6315 | — |
| Novo Nordisk Clinical Trial Call Center | Lackland Air Force Base | Texas | 78236-5300 | — |
| Novo Nordisk Clinical Trial Call Center | San Antonio | Texas | 78229-3900 | — |
| Novo Nordisk Clinical Trial Call Center | Salt Lake City | Utah | 84143 | — |
| Novo Nordisk Clinical Trial Call Center | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00323570, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 27, 2012 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00323570 live on ClinicalTrials.gov.